CN119365195A - 含有匹米替比的医药组合物 - Google Patents

含有匹米替比的医药组合物 Download PDF

Info

Publication number
CN119365195A
CN119365195A CN202380046118.5A CN202380046118A CN119365195A CN 119365195 A CN119365195 A CN 119365195A CN 202380046118 A CN202380046118 A CN 202380046118A CN 119365195 A CN119365195 A CN 119365195A
Authority
CN
China
Prior art keywords
pharmaceutical composition
crystalline cellulose
tablet
manufactured
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380046118.5A
Other languages
English (en)
Chinese (zh)
Inventor
西山哲矢
仁木悠一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of CN119365195A publication Critical patent/CN119365195A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202380046118.5A 2022-06-10 2023-06-09 含有匹米替比的医药组合物 Pending CN119365195A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022094420 2022-06-10
JP2022-094420 2022-06-10
PCT/JP2023/021535 WO2023238929A1 (ja) 2022-06-10 2023-06-09 ピミテスピブを含有する医薬組成物

Publications (1)

Publication Number Publication Date
CN119365195A true CN119365195A (zh) 2025-01-24

Family

ID=89118411

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380046118.5A Pending CN119365195A (zh) 2022-06-10 2023-06-09 含有匹米替比的医药组合物

Country Status (10)

Country Link
US (1) US20250312280A1 (https=)
EP (1) EP4537824A1 (https=)
JP (1) JPWO2023238929A1 (https=)
KR (1) KR20250022143A (https=)
CN (1) CN119365195A (https=)
AU (1) AU2023282693A1 (https=)
CA (1) CA3258968A1 (https=)
MX (1) MX2024015327A (https=)
TW (1) TW202404585A (https=)
WO (1) WO2023238929A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4608087B2 (ja) * 1999-12-22 2011-01-05 富山化学工業株式会社 固形製剤の製造法
PT2452940E (pt) 2009-07-10 2015-02-27 Taiho Pharmaceutical Co Ltd Composto azabiciclo e seu sal
EP2498759B1 (en) * 2009-11-13 2018-08-01 AstraZeneca AB Immediate release tablet formulations
MX353289B (es) * 2011-05-25 2018-01-05 Taiho Pharmaceutical Co Ltd Tableta revestida en seco que contiene tegafur, gimeracil y oteracil potasico.
RU2657783C2 (ru) 2013-09-30 2018-06-15 Тайхо Фармасьютикал Ко., Лтд. Комбинированная терапия с использованием азабициклосоединения для ракового заболевания
JP6537601B2 (ja) 2015-05-12 2019-07-03 大鵬薬品工業株式会社 アザ二環式化合物の結晶
DK3646869T3 (da) 2017-06-30 2025-09-15 Taiho Pharmaceutical Co Ltd Kemoterapi mod kræft under anvendelse af azabicycloforbindelse
BR112020005100A2 (pt) 2017-09-15 2020-09-15 Taiho Pharmaceutical Co., Ltd. usos de um composto inibidor de hsp90 para produzir um agente profilático e/ou terapêutico para doenças que envolvem expressão de ido e para produzir uma composição farmacêutica para tratar tumores ido-positivos
JP6918204B2 (ja) * 2018-03-19 2021-08-11 大鵬薬品工業株式会社 アルキル硫酸ナトリウムを含む医薬組成物
AU2018423606B2 (en) 2018-05-14 2024-10-10 Taiho Pharmaceutical Co., Ltd. Method of treating malignant tumor by azabicyclic compound

Also Published As

Publication number Publication date
CA3258968A1 (en) 2025-04-18
EP4537824A1 (en) 2025-04-16
TW202404585A (zh) 2024-02-01
KR20250022143A (ko) 2025-02-14
WO2023238929A1 (ja) 2023-12-14
US20250312280A1 (en) 2025-10-09
MX2024015327A (es) 2025-02-10
AU2023282693A1 (en) 2025-01-02
JPWO2023238929A1 (https=) 2023-12-14

Similar Documents

Publication Publication Date Title
JP5794650B2 (ja) 難溶性薬物の溶解性改善製剤
WO2008072534A1 (ja) マンニトール又は乳糖を含有する固形製剤
TW201938564A (zh) 包含烷基硫酸鈉之醫藥組合物
CN111565720A (zh) 控释制剂
JP2010536798A (ja) 難溶性薬物の生体利用率を制御するための方法及び組成物
US8703188B1 (en) Dispersible tablet
EP3886817A1 (en) Pharmaceutical composition comprising ramipril and indapamide
TW200808358A (en) Galenical formulations of organic compounds
WO2022138717A1 (ja) 経口固形製剤
TWI436760B (zh) 阿利克侖之蓋崙（ｇａｌｅｎｉｃａｌ）調配物
KR102286499B1 (ko) 레날리도마이드를 포함하는 약제학적 조성물
CN119365195A (zh) 含有匹米替比的医药组合物
US9675549B2 (en) Tablet containing composite with cyclodextrin
RU2857663C2 (ru) Фармацевтическая композиция, содержащая пимитеспиб
JP2017210435A (ja) イルベサルタン及びアムロジピンベシル酸塩配合錠の製造方法
EP4279075B1 (en) A pharmaceutical composition comprising elagolix
HK40115959A (zh) 含有匹米替比的医药组合物
KR20250041176A (ko) 나포라페닙을 포함하는 무정형 고체 분산물
JP2025122084A (ja) レボドパ持続性製剤
WO2026019402A1 (en) A pharmaceutical composition comprising nanosuspension of canagliflozin
KR20250048897A (ko) 용해도 및 안정성이 개선된 팔보시클립을 포함하는 약학 조성물
TW202300138A (zh) 拉考沙胺藥物組合物、其製備方法及應用
TW202333702A (zh) 具有優異溶出性之醫藥組成物
JP2021070658A (ja) アビラテロン酢酸エステル含有製剤
JP2022021916A (ja) イストラデフィリン含有口腔内崩壊錠

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40115959

Country of ref document: HK